top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Malignant Mesothelioma
Malignant Mesothelioma
Autore L. Pouliquen Daniel
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (328 p.)
Soggetto topico Medicine
Soggetto non controllato asbestos
asbestos exposure
BAP1
biomarkers
cancer biomarkers
cancer-specific mutations
cancers
carbon nanotubes
carcinogenesis
CDKN2A
circulating tumor DNA
dendritic cells
DNA damage response
DNA methylation
DNA sequencing
drug repurposing
epigenome-wide analysis
epithelioid
extrapleural pneumonectomy
fatty acid-binding protein
FDG
first line
gene expression
genomics
Hippo pathway
histotype
immune therapy
immunogenicity
immunohistochemistry
immunotherapy
infiltrating immune cells
inflammation
interaction analysis
laminin subunit beta-2
liquid biopsies
lurbinectedin
lymphocyte-to-monocyte ratio
macrophage-capping protein
malignant mesothelioma
malignant pleural mesothelioma
mesothelioma
mesothelium
meta-analysis
metabolomics
MPM
MTAP
mutation
n/a
network analysis
NF2
oxidative stress
PET-CT
plasma
pleural effusion
pleural mesothelioma
pleurectomy decortication
predictive biomarker
prognostic biomarker
protein-protein interactions
proteomics
PTCH1
radiotherapy
redox-sensitive factors
sarcomatoid
selenium-binding protein 1
SETD2
survival
survival analysis
systematic review
systems biology
targeted therapy
therapy response
tumor microenvironment
tumor suppressor
tumor-associated macrophages
VATS
WDPM
well-differentiated papillary mesothelioma
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557359303321
L. Pouliquen Daniel  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Mitochondria-targeted drug delivery
Mitochondria-targeted drug delivery
Autore Kopecka Joanna
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (290 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato alkylphospholipid analog
anticancer peptide (ACP)
anticancer peptides
antimicrobial peptide (AMP)
antimicrobial peptides
antitumor agents
ATP production
blood-brain barrier
cancer drug resistance
cancer metabolism
cardiovascular disease
central nervous system
cholesterol
cytotoxic effect
differentiation
diphenyleneiodonium
drug delivery
edelfosine
endothelial
fluorescence lifetime imaging
gene therapy
heteroplasmy
host defense peptides
hypoxia
inflammation
lipid raft
LPS
malate-aspartate shuttle
medicinal chemistry
melanoma
metabolic drug
metabolism
mitochondria
mitochondria dysfunctions
mitochondria-targeted antioxidants
mitochondrial carrier
mitochondrial disease
mitochondrial disorders
mitochondrial DNA
mitochondrial gene delivery
mitochondrial oncometabolites
mitochondrial permeability transition pore
mitochondrial ROS
n/a
NADPH-oxidase
nanocarriers
neuron
oxidative stress
oxoglutarate carrier
pharmacological therapy
plumbagin
precision medicine
prediction
proliferation
random forest
reactive oxygen species
retinal ischemia
tunneling nanotubules
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576881503321
Kopecka Joanna  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui